Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 1/2018

01-01-2018 | Concise Research Letters

Variations in Instructed vs. Published Word Counts in Top Five Medical Journals

Authors: Orli Silverberg, BSc, Joel G. Ray, MD MSc

Published in: Journal of General Internal Medicine | Issue 1/2018

Login to get access

Excerpt

Medical journals set word limits for research papers. After editorial and peer review, manuscripts are revised for additional detail and clarity. Assuming that a published article reflects the best possible version of a given paper, we assessed the degree to which the word count in each published article deviated from that in the journal’s instructions for authors. …
Literature
1.
2.
Falagas ME, Zarkali A, Karageorgopoulos DE, Bardakas V, Mavros MN. The impact of article length on the number of future citations: a bibliometric analysis of general medicine journals. PLoS ONE. 2013;8: e49476.CrossRef
3.
Metadata
Title
Variations in Instructed vs. Published Word Counts in Top Five Medical Journals
Authors
Orli Silverberg, BSc
Joel G. Ray, MD MSc
Publication date
01-01-2018
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 1/2018
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-017-4196-6

Other articles of this Issue 1/2018

Journal of General Internal Medicine 1/2018 Go to the issue

Editorial

CHAD is Dead: Pragmatic Utility of the CHA2DS2-VASc Score in Non-Valvular Atrial Fibrillation?

Original Research

Primary Care Tasks Associated with Provider Burnout: Findings from a Veterans Health Administration Survey

Original Research

Effect of Reminding Patients to Complete Fecal Immunochemical Testing: A Comparative Effectiveness Study of Automated and Live Approaches

Original Research

Overtreatment and Deintensification of Diabetic Therapy among Medicare Beneficiaries

Innovation and Improvement: Innovations in Medical Education

Warm Handoffs: a Novel Strategy to Improve End-of-Rotation Care Transitions

Concise Research Reports

Evidence-Based Precision Medicine is Needed to Move Toward General Internal Precision Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits